This company has been marked as potentially delisted and may not be actively trading. Soaring Eagle Acquisition (SRNG) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock SRNG vs. ADMA, KRYS, PCVX, ACLX, SWTX, CRSP, SRRK, IMVT, ALVO, and DNLIShould you be buying Soaring Eagle Acquisition stock or one of its competitors? The main competitors of Soaring Eagle Acquisition include ADMA Biologics (ADMA), Krystal Biotech (KRYS), Vaxcyte (PCVX), Arcellx (ACLX), SpringWorks Therapeutics (SWTX), CRISPR Therapeutics (CRSP), Scholar Rock (SRRK), Immunovant (IMVT), Alvotech (ALVO), and Denali Therapeutics (DNLI). Soaring Eagle Acquisition vs. ADMA Biologics Krystal Biotech Vaxcyte Arcellx SpringWorks Therapeutics CRISPR Therapeutics Scholar Rock Immunovant Alvotech Denali Therapeutics ADMA Biologics (NASDAQ:ADMA) and Soaring Eagle Acquisition (NASDAQ:SRNG) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, community ranking, dividends, profitability, earnings, media sentiment, valuation and risk. Does the MarketBeat Community prefer ADMA or SRNG? ADMA Biologics received 414 more outperform votes than Soaring Eagle Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformADMA BiologicsOutperform Votes41472.13% Underperform Votes16027.87% Soaring Eagle AcquisitionN/AN/A Do analysts recommend ADMA or SRNG? ADMA Biologics presently has a consensus target price of $22.50, indicating a potential downside of 4.34%. Given ADMA Biologics' stronger consensus rating and higher probable upside, research analysts clearly believe ADMA Biologics is more favorable than Soaring Eagle Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ADMA Biologics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Soaring Eagle Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to ADMA or SRNG? In the previous week, ADMA Biologics had 22 more articles in the media than Soaring Eagle Acquisition. MarketBeat recorded 22 mentions for ADMA Biologics and 0 mentions for Soaring Eagle Acquisition. ADMA Biologics' average media sentiment score of 0.93 beat Soaring Eagle Acquisition's score of 0.20 indicating that ADMA Biologics is being referred to more favorably in the media. Company Overall Sentiment ADMA Biologics Positive Soaring Eagle Acquisition Neutral Do institutionals and insiders hold more shares of ADMA or SRNG? 75.7% of ADMA Biologics shares are owned by institutional investors. Comparatively, 41.2% of Soaring Eagle Acquisition shares are owned by institutional investors. 3.7% of ADMA Biologics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has stronger valuation & earnings, ADMA or SRNG? Soaring Eagle Acquisition has lower revenue, but higher earnings than ADMA Biologics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioADMA Biologics$426.45M13.11-$28.24M$0.8228.68Soaring Eagle AcquisitionN/AN/AN/AN/AN/A Is ADMA or SRNG more profitable? ADMA Biologics has a net margin of 17.80% compared to Soaring Eagle Acquisition's net margin of 0.00%. ADMA Biologics' return on equity of 53.20% beat Soaring Eagle Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets ADMA Biologics17.80% 53.20% 26.07% Soaring Eagle Acquisition N/A N/A N/A SummaryADMA Biologics beats Soaring Eagle Acquisition on 13 of the 13 factors compared between the two stocks. Get Soaring Eagle Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for SRNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRNG vs. The Competition Export to ExcelMetricSoaring Eagle AcquisitionBiological Products, Except Diagnostic IndustryEnergy SectorNASDAQ ExchangeMarket Cap$1.52B$2.97B$7.20B$8.03BDividend YieldN/A1.87%10.64%4.23%P/E RatioN/A30.5248.6918.87Price / SalesN/A493.1223,725.63106.84Price / CashN/A168.6835.6834.62Price / BookN/A3.213.464.34Net IncomeN/A-$72.35M$4.33B$248.06M Soaring Eagle Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRNGSoaring Eagle AcquisitionN/A$7.04+1.1%N/A+726.5%$1.52BN/A0.00N/AGap UpADMAADMA Biologics1.4828 of 5 stars$23.27-2.2%$22.50-3.3%+249.0%$5.53B$426.45M83.11530Upcoming EarningsOptions VolumeNews CoverageGap UpKRYSKrystal Biotech4.9066 of 5 stars$165.69-2.5%$222.71+34.4%+3.7%$4.79B$290.52M55.41210Upcoming EarningsAnalyst RevisionNews CoveragePositive NewsPCVXVaxcyte2.9066 of 5 stars$35.24-1.7%$136.50+287.3%-45.2%$4.54BN/A-7.66160Upcoming EarningsNews CoveragePositive NewsHigh Trading VolumeACLXArcellx2.0158 of 5 stars$65.53+0.9%$110.67+68.9%+23.0%$3.61B$107.94M-92.2980Upcoming EarningsNews CoveragePositive NewsSWTXSpringWorks Therapeutics2.1458 of 5 stars$46.21-0.2%$52.57+13.8%+6.6%$3.47B$191.59M-13.28230Analyst ForecastNews CoverageHigh Trading VolumeCRSPCRISPR Therapeutics3.0172 of 5 stars$37.73-2.4%$73.11+93.8%-30.5%$3.26B$35M-8.63473Upcoming EarningsPositive NewsSRRKScholar Rock4.0674 of 5 stars$32.76-0.5%$42.67+30.2%+117.9%$3.11B$33.19M-13.94140Upcoming EarningsInsider TradeNews CoveragePositive NewsGap DownIMVTImmunovant2.3635 of 5 stars$15.90-1.5%$38.33+141.1%-45.1%$2.70BN/A-6.07120ALVOAlvotech1.8369 of 5 stars$7.94+1.3%$18.00+126.7%-43.3%$2.39B$489.68M-4.294Short Interest ↑News CoverageDNLIDenali Therapeutics4.0747 of 5 stars$16.06-3.5%$37.57+133.9%-2.2%$2.33B$330.53M-5.82430Upcoming EarningsPositive NewsGap Up Related Companies and Tools Related Companies ADMA Alternatives KRYS Alternatives PCVX Alternatives ACLX Alternatives SWTX Alternatives CRSP Alternatives SRRK Alternatives IMVT Alternatives ALVO Alternatives DNLI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRNG) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soaring Eagle Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soaring Eagle Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SRNG Stock Free SRNG Stock Alerts